You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
潤達醫療(603108.SH)業績快報:半年度淨利潤降36.28%至1.11億元
格隆匯 07-30 19:18

格隆匯 7 月 30日丨潤達醫療(603108.SH)發佈2020年半年度業績快報,實現營業總收入29.43億元,同比減少10.67%;歸屬於上市公司股東的淨利潤1.11億元,同比下降36.28%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.08億元,同比下降39.87%;基本每股收益0.19元。

響經營業績的主要原因系報告期內公司主營業務受疫情影響,常規檢測需求階段性下滑。隨着疫情逐步緩解,二季度公司業績已逐步恢復。

從月度來看,20202月至4月,醫院住院量、門診量及手術量急劇下降導致部分常規檢測量大幅下滑。二季度全國疫情有所緩解,業務量逐月提升,6月份整體營業收入已達去年同期水平。另外,二季度個別地區出現疫情反彈,當地子公司受其影響較大,對公司整體業績產生一定影響。

分地區來看,華中地區營業收入較去年同期增長55%左右,西南地區較去年同期增長近15%,華東地區較去年同比下滑約12%,華北、東北地區受北京及東北地區的疫情反彈影響,營業收入較去年同期下滑30%左右。從全國來看,未出現疫情反彈的地區的相關業務已逐步恢復到去年同期水平。

影響利潤下滑的主要原因是受疫情影響收入下降,公司固定資產折舊、固定費用未因此減少,同時公司在疫情期間進行了部分捐贈導致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account